ID 2499 - Proantocyjanidyny z żurawiny

PL: Proantocyjanidyny z żurawiny
EN: Vaccinium macrocarpon, oxycoccus (Common Name : Cranberry)
Pdf: proanthocyanidins from cranberry

1. Charakterystyka żywności / składnika

The foods/food constituents that are the subject of the health claims are “Sqeez Cranberry Juice Drink”, “proanthocyanidins in cranberry juice”, “Vaccinium macrocarpon, oxycoccus (Common Name: Cranberry)”, “whole cranberry powder from North American Cranberry (Vaccinium macrocarpon) Early Black species”, and “cranberry extract powder (Vaccinium macrocarpon)”.
In the information provided, a number of food products derived from two varieties of cranberry (Vaccinium macrocarpon Aiton and Vaccinium oxycoccos L.) fruit were mentioned i.e. cranberry juice; diluted cranberry juice concentrate; cranberry juice cocktails; cranberry extracts, powders, and capsules. The Panel notes that the composition and/or manufacturing process for these cranberry-derived food products are not specified in the information provided. The Panel also notes that no human studies have been provided using cranberry fruit products derived from V. oxycoccos L.
The conditions of use related to some of these claims specify the amount of cranberry fruit products to be consumed in order to obtain the claimed effects in relation to their proanthocyanidin (PAC) content. The PAC fraction isolated from cranberries (V. macrocarpon Aiton) is a mixture of catechin and epicatechin oligomers of various molecular weights, and consists of predominantly procyanidin pentamers and tetramers containing at least one A-type linkage (Cunningham et al., 2002; Foo et al., 2000).
The Panel considers that whereas various food products derived from cranberry fruits, i.e. cranberry juice; diluted cranberry juice concentrate; cranberry juice cocktails; cranberry extracts, powders, and capsules, are not sufficiently characterised in relation to the claimed effects, PAC from cranberry (V. macrocarpon Aiton) fruit are sufficiently characterised.

2.3. Zdrowie serca (ID 2499)

The claimed effect is “heart health”. The Panel assumes that the target population is the general population.
The claimed effect is not sufficiently defined, and no further details were provided in the proposed wordings or clarifications provided by Member States.
The Panel considers that the claimed effect is general and non-specific, and does not refer to any specific health claim as required by Regulation (EC) No 1924/2006.

Warunki i możliwe ograniczenia stosowania oświadczenia

Concentrated cranberry (12:1): 140 mg / Concentrated cranberry juice: 2,7 g / Used as part of a multibotanical combination